≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Oesophagus

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_OESOPHAGUS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D13.0&
  • Hospital discharge: ICD-9 — 2110
  • Hospital discharge: ICD-8 — 2110
  • Cause of death: ICD-10 — D13.0&
  • Cause of death: ICD-9 — 2110
  • Cause of death: ICD-8 — 2110

2 out of 7 registries used, show all original rules.

416

4. Check minimum number of events

None

416

5. Include endpoints

None

416

6. Filter based on genotype QC (FinnGen only)

416

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D13
Name in latin
Neoplasma benignum oesophagi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2379 1167 1194
Only index persons 2084 1051 1033
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.04 0.04 0.04
Median age at first event (years)
Whole population 61.50 61.77 61.20
Only index persons 60.86 60.89 60.82

-FinnGen-

Key figures

All Female Male
Number of individuals 416 222 194
Unadjusted period prevalence (%) 0.08 0.08 0.09
Median age at first event (years) 61.02 58.92 63.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
383
Matched controls
3828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
+∞
323.0
371
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
15.7
121.9
307
783
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
78.2
37.8
42
6
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
22.2
36.9
54
28
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
392.3
36.6
36
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
65.9
31.7
36
6
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
5.3
28.6
97
230
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
17.9
25.1
39
24
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
243.9
22.9
23
*
R13
ICD-10 Finland
Dysphagia
5.7
21.0
63
127
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
10.5
20.4
40
42
UJD02
NOMESCO Finland
Gastroscopy
6.2
19.5
54
98
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.9
18.8
65
153
K22.7
ICD-10 Finland
Barrett oesophagus
21.3
18.0
26
13
A02BC02
ATC
pantoprazole; systemic
2.7
16.7
285
1998
A02BC05
ATC
esomeprazole; systemic
2.5
16.2
197
1141
UJF32
NOMESCO Finland
Coloscopy
2.7
16.0
140
674
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
47.0
15.2
18
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
155.7
14.6
15
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
23.3
14.4
20
9
UJC12
NOMESCO Finland
Flexible oesophagoscopy
18.4
14.0
21
12
A02BC01
ATC
omeprazole; systemic
2.5
13.7
137
698
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.5
13.5
68
224
K22.1
ICD-10 Finland
Ulcer of oesophagus
9.6
13.5
27
30
K22.2
ICD-10 Finland
Oesophageal obstruction
14.0
12.1
20
15
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
67.0
11.7
13
*
JCA05
NOMESCO Finland
Endoscopic polypectomy in oesophagus
+∞
10.5
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
10.4
104
519
A02BC03
ATC
lansoprazole; oral
2.1
9.5
135
787
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.4
188
1254
WX002
NOMESCO Finland
Sedation and analgesia
2.3
9.0
97
497
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
8.9
97
499
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
4.7
8.8
29
66
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
51.2
8.7
10
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
8.2
87
443
Z2221
NOMESCO Finland
Medical doctor
2.0
8.1
123
729
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
10.4
8.1
15
15
K20
ICD-10 Finland
Oesophagitis
6.8
8.0
19
29
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
11.1
7.9
14
13
UJC02
NOMESCO Finland
Rigid oesophagoscopy
12.2
7.6
13
11
WX402
NOMESCO Finland
General anaesthesia
2.3
7.6
77
383
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
81.6
7.4
8
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
81.6
7.4
8
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
81.6
7.4
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
7.3
58
253
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
7.3
141
905
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
30.6
7.2
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
7.2
116
700
C16.00
ICD-10 Finland
Cardia
20.5
7.2
10
5
R4190
NOMESCO Finland
Nutritional therapy
4.5
7.2
24
56
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.0
6.9
39
139
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.4
6.9
32
100
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
6.9
43
163
H02AB06
ATC
prednisolone; systemic
1.8
6.9
179
1266
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
17.1
6.8
10
6
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
6.7
77
403
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.9
6.7
26
70
K90.0
ICD-10 Finland
Coeliac disease
5.0
6.6
20
42
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.9
6.6
13
15
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
10.3
6.6
12
12
R03BA01
ATC
beclometasone; inhalant
2.3
6.5
61
290
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.5
327
2833
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
71.0
6.4
7
*
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
71.0
6.4
7
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
9.5
6.3
12
13
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
+∞
6.3
6
*
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
27.1
6.2
8
*
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
6.2
36
132
K30
ICD-10 Finland
Functional dyspepsia
2.5
6.2
47
203
JN4BD
NOMESCO Finland
Extensive body CT
2.3
6.1
56
263
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
12.8
6.1
10
8
J02AC01
ATC
fluconazole; systemic
1.8
6.1
144
978
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.2
6.0
30
100

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
177
475
5.75
65.92
2.1
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
249
1491
2.67
20.96
7.7
4.9
g/l
35.1
35.4
0.38
231
1392
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
277
1829
2.54
17.76
7.8
6.6
umol/l
11.1
11.2
0.07
266
1728
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
86
324
3.09
17.41
2.7
2.4
g/l
0.2
0.2
0.05
78
305
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1079
2.40
16.78
3.0
2.6
u/l
54.4
56.7
0.49
171
1002
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
353
2667
3.14
16.58
10.2
7.6
u/l
79.5
79.0
0.10
330
2488
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
160
846
2.45
16.53
2.9
2.0
mg/l
3.1
3.2
0.28
144
722
(3003458) Phosphate [Moles/volume] in Serum or Plasma
97
420
2.71
15.05
10.6
6.0
mmol/l
1.1
1.0
0.97
90
388
(3032080) INR in Blood by Coagulation assay
227
1446
2.25
14.71
12.8
9.6
inr
1.2
1.2
0.35
54
423
(42870588) Differential panel, method unspecified - Blood
184
1101
2.20
13.63
7.5
5.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
235
1587
2.11
12.33
11.3
5.6
mmol/l
1.2
1.2
0.01
209
1433
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
249
1725
2.10
12.12
12.1
6.6
mmol/l
1.2
1.2
0.04
208
1458
(3001604) Monocytes [#/volume] in Blood
242
1662
2.09
12.02
7.6
5.6
e9/l
0.6
0.6
0.23
206
1442
(3006315) Basophils [#/volume] in Blood
242
1675
2.06
11.61
7.6
5.6
e9/l
0.0
0.0
0.20
206
1456
(3013826) Glucose [Moles/volume] in Serum or Plasma
277
2019
2.11
11.50
9.8
4.6
mmol/l
6.7
6.7
0.02
257
1882
(3019198) Lymphocytes [#/volume] in Blood
244
1701
2.05
11.39
7.6
5.6
e9/l
1.9
1.9
0.01
213
1506
(3022096) Basophils/100 leukocytes in Blood
224
1515
2.04
11.37
7.9
5.7
%
0.7
0.7
0.94
208
1411
(3013650) Neutrophils [#/volume] in Blood by Automated count
267
1932
2.07
11.14
11.5
9.5
e9/l
4.4
4.1
1.17
232
1705
(3013115) Eosinophils [#/volume] in Blood
245
1726
2.02
10.93
8.3
5.8
e9/l
0.2
0.2
1.11
214
1525
(3002030) Lymphocytes/100 leukocytes in Blood
231
1600
2.00
10.75
8.0
5.8
%
26.2
27.2
0.76
212
1485
(3020779) Urea [Moles/volume] in Serum or Plasma
66
279
2.62
10.53
12.6
8.5
mmol/l
9.3
10.0
0.34
59
268
(3006504) Eosinophils/100 leukocytes in Blood
226
1570
1.96
10.25
8.0
5.6
%
2.6
2.8
0.47
210
1458
(3019069) Monocytes/100 leukocytes in Blood
226
1575
1.95
10.10
8.2
5.9
%
8.6
8.7
0.11
209
1475
(3022948) Iron [Moles/volume] in Serum or Plasma
102
537
2.19
9.92
3.5
2.4
umol/l
10.7
13.3
3.42
96
494
(3044640) Blood type and Crossmatch panel - Blood
166
1057
1.95
9.56
4.3
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
206
1416
1.90
9.36
4.2
2.6
ug/l
115.2
129.6
0.40
190
1291
(3018010) Neutrophils/100 leukocytes in Blood
224
1586
1.89
9.25
8.0
5.6
%
58.7
57.7
0.57
206
1484
(3000991) Gas panel - Venous blood
64
284
2.48
9.20
17.3
7.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
117
3.27
9.18
1.8
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
138
836
1.97
9.11
1.8
1.5
nmol/l
21.5
21.1
0.11
124
700
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
269
2.49
8.87
3.0
3.2
ng/l
197.5
207.7
0.08
55
241
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
219
1564
1.85
8.57
5.3
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
204
1429
1.84
8.46
2.4
2.0
pmol/l
95.8
94.2
0.19
120
747
(3022145) Colonoscopy Study observation
77
386
2.22
8.35
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
356
3013
2.26
8.03
29.6
15.8
%
38.8
39.8
1.22
229
2103
(3037467) Urinalysis macro (dipstick) panel - Urine
295
2341
1.89
7.94
4.9
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
130
803
1.90
7.93
4.4
2.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
78
403
2.15
7.83
16.6
6.7
kpa
11.4
12.1
0.65
72
385
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
78
403
2.15
7.83
16.7
6.7
kpa
5.1
5.1
0.11
72
385
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
188
2.63
7.81
14.9
8.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
312
2.28
7.80
2.6
2.4
u/l
34.0
31.4
0.30
48
264
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
208
2.54
7.70
1.1
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
77
400
2.14
7.61
16.8
6.8
mmol/l
1.3
1.1
0.15
64
316
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
669
1.92
7.51
4.5
3.8
ng/l
645.6
279.0
0.31
88
534
(3023368) Bacteria identified in Blood by Culture
147
971
1.79
7.10
6.3
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
278
2208
1.78
6.98
4.1
3.2
u/l
55.7
50.0
0.48
247
2039
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
468
2.00
6.84
3.8
2.4
%
18.5
22.7
2.48
71
402
(3026008) Bacteria identified in Urine by Culture
152
1025
1.76
6.78
2.8
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
389
2.06
6.71
3.2
3.1
umol/l
6.8
9.2
0.73
61
342
(3018418) pH of Serum or Plasma
155
1057
1.74
6.62
6.3
3.9
ph
7.4
7.4
0.37
29
204
(3042936) Bacteria identified in Isolate by Culture
91
529
1.92
6.54
2.7
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
1104
1.73
6.53
4.7
3.5
u/l
28.2
31.7
1.50
152
1056
(3013707) Erythrocyte sedimentation rate by Westergren method
306
2530
1.79
6.36
5.1
4.1
mm/h
14.9
12.0
1.97
272
2313
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
379
3371
2.40
6.30
26.0
14.7
mg/l
22.5
24.4
0.65
314
2650
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
243
2.25
6.21
4.6
3.6
ng/l
112.0
83.1
1.02
43
213
(3014576) Chloride [Moles/volume] in Serum or Plasma
79
445
1.96
6.21
16.0
6.2
mmol/l
104.1
104.0
0.06
79
431
(3015377) Calcium [Moles/volume] in Serum or Plasma
167
1180
1.69
6.17
3.7
3.5
mmol/l
2.3
2.3
0.31
142
1024
(3037522) Nuclear Ab [Titer] in Serum
77
431
1.97
6.16
1.2
1.3
titre
301.2
479.6
0.81
17
99
(3048689) Calprotectin [Mass/mass] in Stool
68
365
2.03
6.11
2.6
2.2
ug/g
138.5
132.7
0.06
48
286
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
64
3.40
5.94
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
64
3.40
5.94
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
241
2.22
5.92
2.0
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
72
402
1.96
5.79
2.8
4.4
ug/l
7.4
41.2
0.99
64
338
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
133
2.61
5.77
1.2
2.2
g/l
6.9
7.4
0.94
26
95
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
133
2.61
5.77
1.2
2.2
g/l
3.5
3.7
0.27
24
91
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
71
3.22
5.70
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
42
3.92
5.59
1.1
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
184
1363
1.63
5.50
2.7
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
149
2.47
5.48
1.9
1.8
g/l
1.3
1.5
0.74
29
127
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
133
2.52
5.27
1.3
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
75
438
1.87
5.25
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
103
668
1.72
5.07
2.0
1.7
nmol/l
1159.3
1202.1
0.14
74
495
(36304419) Bacteria [Presence] in Urine
135
942
1.64
5.04
3.7
3.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
350
3084
1.85
5.03
5.7
4.6
mu/l
1.9
2.3
0.53
322
2770
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
124
2.53
5.01
1.2
2.3
g/l
3.1
3.2
0.05
25
92
(3019550) Sodium [Moles/volume] in Serum or Plasma
383
3496
2.20
4.72
31.0
17.1
mmol/l
139.4
139.6
0.98
375
3400
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
182
1381
1.57
4.72
2.7
2.3
nmol/l
74.0
77.4
0.92
159
1216
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
167
1246
1.57
4.64
3.8
3.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
28
117
2.49
4.58
2.0
2.0
ug/l
412.2
308.1
0.16
28
110
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
660
1.68
4.58
3.3
3.1
mmol/l
2.5
2.4
0.33
84
578
(3023103) Potassium [Moles/volume] in Serum or Plasma
383
3504
2.17
4.55
31.2
17.3
mmol/l
4.0
4.0
0.70
375
3407
(3030467) Casts [#/volume] in Urine by Automated count
136
973
1.59
4.50
3.8
3.1
e6/l
0.4
0.5
0.65
101
727
(3035350) Ketones [Presence] in Urine by Test strip
209
1649
1.54
4.47
3.7
3.6
estimate
0.0
0.0
0.00
32
326
(3018095) Leukocytes [#/volume] in Urine
163
1220
1.55
4.42
4.3
3.7
e6/l
67.7
70.7
0.04
114
877
(3044889) 12 lead EKG panel
286
2431
1.56
4.26
4.5
4.0
—
—
—
0
0
(4035726)
55
311
1.89
4.24
1.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
119
842
1.58
4.07
7.5
6.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
207
1655
1.50
4.01
5.1
4.9
estimate
0.0
0.0
0.00
33
324
(3002385) Erythrocyte distribution width [Ratio]
318
2786
1.60
4.00
31.2
18.3
%
14.2
13.7
3.06
313
2745
(3002032) Base excess in Venous blood by calculation
54
311
1.85
3.94
4.4
4.2
mmol/l
1.8
1.9
0.11
47
242
(3052851) Hemolysis interference index of Serum or Plasma
23
95
2.50
3.87
2.5
3.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
67
414
1.74
3.87
2.1
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
208
1675
1.48
3.83
3.7
3.7
estimate
0.0
0.0
0.50
31
313
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
88
587
1.63
3.82
3.0
2.8
e6/l
1.0
1.1
0.08
44
336
(3027945) Reticulocytes/100 erythrocytes in Blood
66
410
1.72
3.74
2.7
2.5
%
1.7
1.8
0.42
59
367
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
177
2.07
3.71
2.6
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
292
2527
1.52
3.71
4.5
3.8
pmol/l
14.5
14.9
1.90
272
2252
(3021589) Normoblasts [#/volume] in Blood
190
1510
1.48
3.70
13.2
9.7
e9/l
0.0
0.0
0.61
154
1250
(3026389) Candida sp identified in Specimen by Organism specific culture
13
40
3.32
3.65
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
105
2.36
3.59
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
550
1.61
3.47
3.1
3.0
e6/l
3.1
2.1
0.29
39
301
(4010399)
44
248
1.87
3.44
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
123
909
1.50
3.38
2.7
2.7
umol/l
3647.7
6293.2
0.32
105
781
(3006653) Thiamine [Moles/volume] in Blood
8
14
5.80
3.35
1.1
1.5
nmol/l
121.8
126.1
—
8
14
(3000492) Spirometry study
51
304
1.77
3.34
1.6
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
105
755
1.52
3.27
1.8
1.8
mg/l
1.0
1.3
0.95
79
598
(3002582) Erythrocytes [#/volume] in Urine
139
1063
1.46
3.20
3.8
3.2
e6/l
96.7
49.3
0.31
107
815
(3000494) Fungus identified in Specimen by Culture
66
429
1.64
3.16
1.8
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
376
3494
1.79
3.13
23.3
13.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
74
2.50
3.09
6.9
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
102
740
1.50
3.03
2.9
2.6
e6/l
6.2
4.5
0.46
91
647
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
107
2.22
3.02
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1361
1.42
3.02
4.1
3.8
ng/l
35.0
38.0
0.14
111
983
(3013512) EKG study
136
1049
1.44
2.95
4.7
3.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
1068
1.44
2.94
2.7
2.0
u/l
182.9
197.9
0.18
133
996
(3007164) IgA [Mass/volume] in Serum or Plasma
90
641
1.52
2.91
1.3
1.4
g/l
2.6
2.6
0.01
49
385
(42529406) Shigella sp [Presence] in Stool by Culture
23
109
2.18
2.90
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
13
5.46
2.88
2.7
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
704
1.49
2.87
1.4
1.2
u/ml
0.5
1.3
2.55
20
192
(3012501) Base excess in Blood by calculation
18
77
2.40
2.86
7.2
3.6
mmol/l
3.0
2.9
0.05
12
50
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
383
3600
1.81
2.75
15.5
10.6
u/l
25.4
25.8
0.24
368
3456
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
82
581
1.51
2.71
2.2
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
348
1.63
2.68
4.0
3.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
135
1.99
2.61
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
74
2.35
2.61
3.5
3.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
47
295
1.67
2.59
3.1
2.6
e9/l
66.4
68.7
0.15
30
235
(36660697) Celiac disease serology panel - Serum
38
225
1.76
2.57
1.3
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
392
3721
1.93
2.57
37.8
21.6
pg
30.2
30.3
0.44
386
3663
(3007461) Platelets [#/volume] in Blood
392
3721
1.93
2.57
38.0
21.7
e9/l
254.9
246.5
1.41
383
3618
(3024731) MCV [Entitic volume]
392
3721
1.93
2.57
37.9
21.6
fl
91.3
91.2
0.15
386
3663
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
44
2.78
2.57
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
392
3722
1.92
2.55
38.0
21.7
e12/l
4.4
4.5
3.40
379
3610
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
88
2.21
2.55
1.5
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
392
3723
1.92
2.53
38.1
21.7
e9/l
7.0
6.7
2.07
380
3614
(3000963) Hemoglobin [Mass/volume] in Blood
392
3724
1.91
2.51
38.3
21.8
g/l
130.9
135.2
5.83
383
3662
(3026782) Osmolality of Urine
94
697
1.45
2.48
2.8
2.8
mosm/kgh2o
530.6
562.1
0.76
85
585
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
137
1088
1.39
2.45
3.0
3.0
ng/l
1477.1
1422.0
0.07
110
922
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
206
1.76
2.43
1.6
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
409
1.55
2.37
2.1
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
71
2.30
2.37
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
356
3311
1.52
2.36
5.5
4.7
mmol/l
6.0
6.0
0.08
327
2998
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
77
556
1.47
2.32
1.3
1.3
iu/ml
31.1
34.7
0.09
31
183
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
60
412
1.53
2.30
2.1
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
47
2.60
2.29
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
48
2.54
2.20
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
48
2.54
2.20
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
722
1.41
2.18
1.8
1.7
pmol/l
479.5
9965472.8
0.50
76
572
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
368
1.54
2.15
1.9
1.6
%
1.9
1.5
0.97
42
313
(40760892) CBC W Ordered Manual Differential panel - Blood
97
744
1.40
2.11
3.8
4.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
98
753
1.39
2.11
3.9
3.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
279
1.60
2.11
2.9
2.7
ml/min/173m2
59.4
64.8
0.43
19
109
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
25
3.24
2.10
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
20
3.54
2.06
1.7
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
22
118
1.91
2.06
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
15
70
2.19
2.00
3.1
2.7
%
14.0
15.9
—
8
35
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
291
1.57
2.00
8.0
4.2
mmol/l
1.2
1.2
0.28
38
254
(3009508) Creatinine [Moles/volume] in Urine
132
1072
1.34
2.00
3.1
3.1
mmol/l
7.4
7.4
0.06
115
884
(3041096) Erythrocytes [Presence] in Urine by Automated
117
938
1.34
1.92
3.0
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
62
446
1.46
1.91
2.1
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
156
1306
1.31
1.90
3.8
3.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
52
2.35
1.89
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
167
1.73
1.89
1.3
1.3
—
—
—
0
0
(4062490)
9
34
2.68
1.87
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
46
2.43
1.86
1.7
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
126
1026
1.33
1.86
3.2
3.3
mg/l
1159.5
184.8
0.65
79
657
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
17
3.56
1.84
8.2
6.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
17
3.56
1.84
2.2
2.9
mu/l
21.5
18.4
—
6
17
(3035320) C reactive protein [Mass/volume] in Body fluid
6
17
3.56
1.84
2.0
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
66
2.16
1.84
2.6
2.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
12
4.20
1.83
1.0
2.8
u/ml
591.0
743.4
—
5
12
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.7
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
103
1.89
1.74
1.7
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
156
1.71
1.73
1.2
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
48
2.33
1.72
1.1
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
329
1.48
1.68
2.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
130
1082
1.29
1.61
3.9
4.1
mg/mmol
5.7
8.8
0.88
82
668
(3019060) Gas panel - Arterial blood
35
232
1.56
1.60
10.4
4.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
32
2.53
1.60
1.1
1.3
nmol/l
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
106
860
1.31
1.59
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
50
2.23
1.58
2.7
2.4
e9/l
5.2
4.9
0.19
11
50
(3004588) Protein electrophoresis panel - Serum or Plasma
35
235
1.53
1.53
1.4
2.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
15
3.36
1.52
1.2
1.1
%
64.4
25.6
—
5
10
(3011648) Oxygen content in Venous blood
7
27
2.62
1.52
1.3
3.4
%
10.5
11.3
—
7
27
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
212
1.55
1.48
2.0
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
9
38
2.40
1.46
1.9
1.3
e6/l
1746.8
1587.1
—
9
24
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
110
1.76
1.45
3.6
2.4
u/ml
0.2
0.3
—
8
59
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
59
2.06
1.45
1.3
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
16
3.15
1.44
1.4
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
53
2.10
1.39
2.8
2.8
%
64.6
58.9
1.25
11
53
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
41
2.22
1.37
3.8
3.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
82
1.86
1.37
1.4
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
17
2.96
1.36
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
184
1.56
1.36
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
90
1.81
1.35
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
68
532
1.33
1.31
1.4
1.3
u/ml
31.6
11.1
0.73
29
219
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
211
1.51
1.29
4.5
3.4
mmol/l
3.3
2.0
0.80
24
159
(3035880) pH of Pleural fluid
5
18
2.80
1.29
1.4
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
18
2.80
1.29
1.0
1.3
%
0.4
1.0
—
5
11
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
490
1.34
1.27
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
110
923
1.26
1.26
1.8
1.6
mmol/l
1.3
1.4
0.44
95
770
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
36
2.25
1.25
1.1
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
25
2.42
1.25
2.5
1.8
e9/l
0.2
0.2
—
6
19
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
85
1.79
1.24
1.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
93
1.75
1.23
1.3
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
78
1.82
1.22
1.6
1.5
iu/l
3.2
6.1
—
5
23
(40760888) Immunoglobulin light chains.free panel - Serum
14
78
1.82
1.22
1.1
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
334
3164
1.28
1.22
6.5
6.0
mmol/mol
40.0
40.2
0.12
299
2920
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
19
2.65
1.22
1.2
1.4
%
23.8
70.5
—
5
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
215
1948
1.21
1.18
3.1
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
184
0.53
1.16
1.7
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
87
1.75
1.16
1.7
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
119
1.63
1.13
2.8
3.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
31
2.28
1.11
1.9
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
32
2.21
1.08
1.1
1.3
u/l
339.0
294.0
—
7
32
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
316
1.37
1.06
2.0
2.5
ug/l
4.9
8.3
1.44
37
278
(3009343) pH of Capillary blood
31
222
1.43
1.04
4.7
3.4
ph
7.4
7.4
—
5
26
(3044941) Cell count panel - Synovial fluid
9
47
1.93
1.02
2.3
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
83
1.71
1.02
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
345
1.34
1.02
1.6
1.6
—
—
—
0
0
(44790047)
9
48
1.89
1.01
1.3
1.6
—
—
—
0
0
(44806118)
9
48
1.89
1.01
1.3
1.6
—
—
—
0
0
(44790049)
9
48
1.89
1.01
1.3
1.6
—
—
—
0
0
(44790048)
9
48
1.89
1.01
1.3
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
336
3207
1.25
1.00
4.1
4.1
mmol/l
1.3
1.3
0.26
301
2903
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
35
2.02
1.00
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
7
35
2.02
1.00
1.9
1.5
mosm/kgh2o
279.9
274.6
—
7
25
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
76
1.73
1.00
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
92
1.65
0.98
1.2
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
36
1.96
0.97
1.4
1.3
pmol/l
152.0
333.9
—
7
29
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
50
1.82
0.97
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
87
733
1.24
0.96
3.9
4.1
kg/l
1.0
1.0
2.06
12
100
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
77
1.71
0.96
1.5
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
117
1.56
0.95
3.0
3.6
g/l
0.2
0.2
—
7
42
(40761536) Microorganisms panel - Urine sediment
39
296
1.35
0.95
5.0
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
376
1.31
0.95
2.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
44
344
1.31
0.89
5.6
4.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
79
1.67
0.89
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
95
1.60
0.88
1.3
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
43
1.88
0.87
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
347
3338
1.24
0.87
4.6
4.6
mmol/l
4.5
4.6
1.12
317
3051
(3022806) Fractional oxyhemoglobin in Capillary blood
8
44
1.83
0.86
2.1
1.9
%
86.3
89.6
—
8
44
(3020891) Body temperature
20
137
1.48
0.85
7.3
3.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
45
1.79
0.84
1.3
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
45
1.79
0.84
1.4
1.3
—
75.1
—
0
5
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
197
1.40
0.84
1.8
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
103
1172
0.84
0.81
3.0
3.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
344
3314
1.22
0.80
4.6
4.5
mmol/l
1.4
1.5
2.32
310
3017
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
268
0.70
0.79
1.9
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
75
1.62
0.75
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
352
3404
1.22
0.75
5.3
5.1
mmol/l
2.7
2.7
0.47
321
3094
(3021788) Differential panel - Synovial fluid
9
54
1.68
0.75
2.1
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
11
68
1.63
0.72
4.5
3.0
nmol/l
0.8
0.8
0.15
11
56
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
333
3208
1.19
0.71
22.9
13.9
ml/min/173m2
78.4
78.7
0.09
279
2639
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
26
1.93
0.71
1.2
1.5
—
62.0
—
0
5
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
26
1.93
0.71
2.2
1.8
e6/l
558.6
505.0
—
5
19
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
26
1.93
0.71
1.6
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
41
1.72
0.70
1.7
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
35
276
1.29
0.69
2.7
4.3
%
0.0
0.2
—
8
86
(3011288) Drugs identified in Urine by Screen method
7
43
1.64
0.67
3.7
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
190
0.67
0.67
2.0
2.9
e6/l
0.1
0.1
0.07
13
185
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
28
1.79
0.66
1.6
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
452
1.22
0.66
4.8
4.5
%
34.1
31.8
1.04
38
292
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
23
172
1.36
0.65
5.8
2.8
u/ml
21.1
37.3
1.14
23
166
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
95
1.49
0.65
1.9
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
33
261
1.29
0.65
2.8
4.3
%
0.0
0.1
—
8
73
(3035637) Corticotropin [Mass/volume] in Plasma
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
445
1.22
0.63
1.6
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
300
1.26
0.60
2.6
4.1
%
0.4
1.0
—
8
97
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
51
1.58
0.60
2.4
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
72
1.54
0.59
1.1
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
53
1.52
0.58
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
73
1.52
0.56
1.3
1.2
—
1.0
—
0
7
(3000330) Specific gravity of Urine by Test strip
22
168
1.33
0.56
2.0
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
37
1.63
0.55
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
60
1.51
0.54
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
66
1.53
0.53
1.8
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
96
0.62
0.52
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
224
1.27
0.52
2.8
2.3
e9/l
3.6
4.0
0.38
17
163
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
1.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(4034850)
7
109
0.64
0.49
7.6
9.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
34
282
1.22
0.48
4.0
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
68
1.48
0.47
1.1
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
94
1.40
0.46
1.2
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
49
1.44
0.46
1.1
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
87
1.39
0.42
1.3
1.3
—
2.5
—
0
13
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
70
1.44
0.42
9.0
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
58
1.39
0.41
1.8
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
34
1.48
0.40
1.8
3.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
71
1.42
0.39
1.7
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
35
1.43
0.39
1.4
2.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(4281824)
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
12
89
1.36
0.38
1.3
1.2
—
2.3
—
0
17
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.38
1.2
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
68
1.33
0.38
1.4
1.2
—
44.6
—
0
6
(3014051) Protein [Presence] in Urine by Test strip
9
69
1.31
0.37
1.3
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
162
1.25
0.36
5.7
3.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
65
718
0.89
0.36
2.7
2.9
ug/l
0.5
0.8
2.44
45
473
(3039443) Prostate specific Ag panel - Serum or Plasma
5
76
0.65
0.36
1.8
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
76
0.65
0.36
1.2
1.3
—
259.2
—
0
35
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
42
1.43
0.35
1.2
4.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.0
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
45
1.34
0.34
2.7
2.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
110
1.28
0.32
1.3
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
240
1.18
0.31
1.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
53
1.33
0.31
1.3
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
129
1.25
0.30
1.3
1.9
—
—
—
0
0
(4094501)
12
94
1.28
0.28
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
76
1.32
0.28
1.7
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
224
1.17
0.28
2.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
187
1.19
0.27
1.8
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
77
1.31
0.26
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
77
1.31
0.26
1.7
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
78
1.29
0.24
1.8
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
10
79
1.27
0.22
1.6
1.1
u/l
9.8
11.3
—
10
62
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
85.7
—
0
10
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
2.4
—
0
6
(3022621) pH of Urine by Test strip
19
219
0.86
0.21
1.7
3.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
14
0.00
0.20
0.0
4.7
—
48.9
—
0
14
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
51
1.18
0.19
3.2
1.8
pg
31.0
32.9
—
6
51
(3004809) Band form neutrophils/100 leukocytes in Blood
6
52
1.16
0.19
1.3
4.0
%
0.5
1.8
—
6
44
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.1
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
29
262
1.11
0.18
1.2
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
60
1.17
0.18
1.9
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
63
1.11
0.17
1.1
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
29
263
1.11
0.17
3.0
4.0
%
0.3
0.4
—
7
63
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
988
0.95
0.14
4.0
4.3
%
21.5
20.8
0.14
44
471
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
1220
0.95
0.14
4.7
4.9
ug/l
1.4
2.7
3.16
103
1080
(1761482) Bacteria [#/volume] in Urine by Culture
8
96
0.83
0.14
2.3
4.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
97
0.82
0.14
2.4
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
149
0.87
0.14
2.9
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
135
1.12
0.10
1.3
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.0
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
64
1.10
0.08
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
87
1.04
0.07
1.7
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
94
923
1.02
0.05
4.6
3.9
estimate
0.0
0.0
0.00
30
318
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
92
1.09
0.03
2.6
2.7
ug/min
31.0
115.6
—
5
56
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
203
1.04
0.01
2.0
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
45
444
1.02
0.00
8.6
6.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
128
1.02
0.00
2.5
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
139
1.01
0.00
2.6
1.7
—
—
—
0
0
(1002224) Polysomnography panel
14
139
1.01
0.00
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
203
0.98
0.00
1.3
1.2
iu/ml
174.8
133.1
—
6
86
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.3
—
0
8
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
4.3
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.6
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
8
83
0.96
0.00
1.1
1.4
e6/l
1.6
15.5
—
8
67
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
82
0.98
0.00
1.1
1.4
mmol/l
3.8
3.8
—
8
77
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.8
—
1.2
—
0
9
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
4.1
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
20.2
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
84
0.95
0.00
1.4
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
8
83
0.96
0.00
1.1
1.5
e6/l
8.0
1443.3
—
8
69
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
68
0.88
0.00
1.2
1.1
u/l
123.9
37.5
—
6
60
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
72
0.97
0.00
1.1
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
62
0.97
0.00
1.8
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_OESOPHAGUS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_OESOPHAGUS 1.743 [1.42, 2.14] < 0.001
Birth year 0.998 [0.99, 1.01] 0.605

During the follow-up period (1.1.1998 — 31.12.2019), 220 out of 904 females with CD2_BENIGN_OESOPHAGUS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_OESOPHAGUS 2.397 [1.96, 2.94] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 354 out of 951 males with CD2_BENIGN_OESOPHAGUS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_OESOPHAGUS.

N-year risk Females Males
1 0.182% 0.547%
5 1.21% 2.914%
10 2.852% 6.638%
15 5.388% 13.23%
20 9.566% 20.951%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_OESOPHAGUS – Benign neoplasm: Oesophagus

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data